Tsuchiya's (2015) study found that lower extremity arterial disease with Rutherford stage 4 was less amputated (12.3%) and death rate after 1 month (6.7%) than in the Rutherford stage 5 or 6 (rates are 22.7% and 33.3%, respectively).